cached image

Pamela B. Davis, M.D., Ph.D. - Publications

Affiliations: 
Case Western Reserve University, Cleveland Heights, OH, United States 

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hsu D, Taylor P, Fletcher D, van Heeckeren R, Eastman J, van Heeckeren A, Davis P, Chmiel JF, Pearlman E, Bonfield T. CF Lung Infection and Inflammation: IL-17 Pathophysiology and Therapeutic Intervention. Infection and Immunity. PMID 27271746 DOI: 10.1128/Iai.00284-16  0.365
2016 Spoonhower KA, Davis PB. Epidemiology of Cystic Fibrosis. Clinics in Chest Medicine. 37: 1-8. PMID 26857763 DOI: 10.1016/J.Ccm.2015.10.002  0.315
2015 Davis PB. Another Beginning for Cystic Fibrosis Therapy. The New England Journal of Medicine. 373: 274-6. PMID 25981385 DOI: 10.1056/Nejme1504059  0.333
2015 Davis PB, Rio SD, Muntz JA, Dieckman L. Sweat chloride concentration in adults with pulmonary diseases. The American Review of Respiratory Disease. 128: 34-37. PMID 6870067 DOI: 10.1164/Arrd.1983.128.1.34  0.325
2015 Davis PB. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis The American Review of Respiratory Disease. 129: 911-914. PMID 6329048 DOI: 10.1164/Arrd.1984.129.6.911  0.365
2012 Drumm ML, Ziady AG, Davis PB. Genetic variation and clinical heterogeneity in cystic fibrosis. Annual Review of Pathology. 7: 267-82. PMID 22017581 DOI: 10.1146/Annurev-Pathol-011811-120900  0.301
2011 Davis PB. Therapy for cystic fibrosis--the end of the beginning? The New England Journal of Medicine. 365: 1734-5. PMID 22047565 DOI: 10.1056/Nejme1110323  0.3
2011 Ziady AG, Davis PB. Methods for evaluating inflammation in cystic fibrosis. Methods in Molecular Biology (Clifton, N.J.). 742: 51-76. PMID 21547726 DOI: 10.1007/978-1-61779-120-8_4  0.4
2011 Chen X, Shank S, Davis PB, Ziady AG. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 93-102. PMID 20959809 DOI: 10.1038/Mt.2010.214  0.328
2009 Nichols DP, Ziady AG, Shank SL, Eastman JF, Davis PB. The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology. 297: L828-36. PMID 19700644 DOI: 10.1152/Ajplung.00171.2009  0.382
2008 Miller TJ, Davis PB. S163 is critical for FXYD5 modulation of wound healing in airway epithelial cells. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 16: 791-9. PMID 19128250 DOI: 10.1111/J.1524-475X.2008.00432.X  0.317
2008 Perez A, van Heeckeren AM, Nichols D, Gupta S, Eastman JF, Davis PB. Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium. American Journal of Physiology. Lung Cellular and Molecular Physiology. 295: L303-13. PMID 18556801 DOI: 10.1152/Ajplung.90276.2008  0.417
2008 Miller TJ, Davis PB. FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia. American Journal of Physiology. Lung Cellular and Molecular Physiology. 294: L654-64. PMID 18263667 DOI: 10.1152/Ajplung.00430.2007  0.345
2007 Konstan MW, Schluchter MD, Xue W, Davis PB. Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 176: 1084-9. PMID 17872492 DOI: 10.1164/Rccm.200702-181Oc  0.312
2007 Davis PB. Pacing the marathon: rate of decline of pulmonary function in cystic fibrosis. The Journal of Pediatrics. 151: 111-3. PMID 17643757 DOI: 10.1016/J.Jpeds.2007.03.060  0.333
2007 Strausbaugh SD, Davis PB. Cystic fibrosis: a review of epidemiology and pathobiology. Clinics in Chest Medicine. 28: 279-88. PMID 17467547 DOI: 10.1016/J.Ccm.2007.02.011  0.322
2007 Davis PB, Cooper MJ. Vectors for airway gene delivery. The Aaps Journal. 9: E11-7. PMID 17408235 DOI: 10.1208/Aapsj0901002  0.31
2007 Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, Davis PB. CFTR inhibition mimics the cystic fibrosis inflammatory profile. American Journal of Physiology. Lung Cellular and Molecular Physiology. 292: L383-95. PMID 16920886 DOI: 10.1152/Ajplung.00403.2005  0.4
2006 Ziady AG, Davis PB. Current prospects for gene therapy of cystic fibrosis. Current Opinion in Pharmacology. 6: 515-21. PMID 16890018 DOI: 10.1016/J.Coph.2006.04.008  0.341
2006 van Heeckeren AM, Schluchter MD, Xue W, Davis PB. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. American Journal of Respiratory and Critical Care Medicine. 173: 288-96. PMID 16272448 DOI: 10.1164/Rccm.200506-917Oc  0.382
2006 Davis PB. Cystic fibrosis since 1938. American Journal of Respiratory and Critical Care Medicine. 173: 475-82. PMID 16126935 DOI: 10.1164/Rccm.200505-840Oe  0.39
2006 Chen X, Davis PB. 397. Compacted DNA Nanoparticles Transfect Cells by Binding to Cell Surface Nucleolin Molecular Therapy. 13: S152. DOI: 10.1016/J.Ymthe.2006.08.459  0.308
2005 Kube DM, Fletcher D, Davis PB. Relation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherence. Respiratory Research. 6: 69. PMID 16008840 DOI: 10.1186/1465-9921-6-69  0.394
2005 Kotlarchyk M, Lee Z, Cooper M, Davis PB, Ziady AG. 1104. Imaging of sec-R Directed and PEG-Stabilized Gene Transfer Nanoparticles in CF Mice Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.652  0.33
2005 Rhee M, Davis PB. 201. C105Y, a Novel Cell Penetrating Peptide Enhances Gene Transfer of Sec-R Targeted Molecular Conjugates Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.204  0.323
2004 Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR, Oette SM, Payne JM, Muhammad O, Ziady AG, Moen RC, et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Human Gene Therapy. 15: 1255-69. PMID 15684701 DOI: 10.1089/Hum.2004.15.1255  0.355
2004 Davis PB, Drumm ML. Some like it hot: curcumin and CFTR. Trends in Molecular Medicine. 10: 473-5. PMID 15464445 DOI: 10.1016/J.Molmed.2004.08.001  0.372
2004 Davis PB, Schluchter MD, Konstan MW. Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis. Pediatric Pulmonology. 38: 204-9. PMID 15274098 DOI: 10.1002/Ppul.20054  0.365
2004 Ziady AG, Kim J, Colla J, Davis PB. Defining strategies to extend duration of gene expression from targeted compacted DNA vectors. Gene Therapy. 11: 1378-90. PMID 15269710 DOI: 10.1038/Sj.Gt.3302299  0.31
2004 Perez A, Davis PB. Gene profile changes after Pseudomonas aeruginosa exposure in immortalized airway epithelial cells. Journal of Structural and Functional Genomics. 5: 179-94. PMID 15263834 DOI: 10.1023/B:Jsfg.0000028982.59273.Bd  0.355
2004 van Heeckeren AM, Schluchter MD, Drumm ML, Davis PB. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 287: L944-52. PMID 15246977 DOI: 10.1152/Ajplung.00387.2003  0.39
2004 van Heeckeren AM, Schluchter M, Xue L, Alvarez J, Freedman S, St George J, Davis PB. Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice. Infection and Immunity. 72: 1479-86. PMID 14977953 DOI: 10.1128/Iai.72.3.1479-1486.2004  0.337
2004 Van Heeckeren AM, Scaria A, Schluchter MD, Ferkol TW, Wadsworth S, Davis PB. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. American Journal of Physiology. Lung Cellular and Molecular Physiology. 286: L717-26. PMID 14514520 DOI: 10.1152/Ajplung.00227.2003  0.369
2004 Ziady AG, Wojtkicwicz G, Davis PB, Lee Z. 832. Radioscintigraphy of sec-R Directed CFTR Gene Transfer in CF Mice Following Intranasal Administration Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.733  0.323
2004 Ziady AG, Poleman J, Heeckeren Cv, Heeckeren Av, Davis PB. 829. Preferential Transfection of Tissue Macrophages Following Intravenous Administration of sec-R Targeted hCFTR DNA Enhances Survival of CF Mice Inoculated with Pseudomonas aeruginosa Agar Beads Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.730  0.369
2004 Ziady AG, Kim J, Colla J, Davis PB. 358. Route of Administration of sec-R Targeted Compacted DNA Influences Both the Site of Expression and Host Immune Response to the Vector Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.286  0.314
2003 Ziady AG, Gedeon CR, Miller T, Quan W, Payne JM, Hyatt SL, Fink TL, Muhammad O, Oette S, Kowalczyk T, Pasumarthy MK, Moen RC, Cooper MJ, Davis PB. Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 936-47. PMID 14664796 DOI: 10.1016/J.Ymthe.2003.07.007  0.347
2003 Chmiel JF, Davis PB. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respiratory Research. 4: 8. PMID 14511398 DOI: 10.1186/1465-9921-4-8  0.371
2003 Konstan MW, Krenicky JE, Finney MR, Kirchner HL, Hilliard KA, Hilliard JB, Davis PB, Hoppel CL. Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects. The Journal of Pharmacology and Experimental Therapeutics. 306: 1086-91. PMID 12807998 DOI: 10.1124/Jpet.103.052449  0.361
2003 Ziady AG, Davis PB, Konstan MW. Non-viral gene transfer therapy for cystic fibrosis. Expert Opinion On Biological Therapy. 3: 449-58. PMID 12783613 DOI: 10.1517/14712598.3.3.449  0.357
2003 Ferkol T, Cohn LA, Phillips TE, Smith A, Davis PB. Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts. American Journal of Respiratory and Critical Care Medicine. 167: 1374-9. PMID 12615618 DOI: 10.1164/Rccm.200209-1119Oc  0.395
2003 Davis PB, Ziady AG. Non-viral methods of gene transfer to airway epithelium Gene Therapy and Regulation. 2: 77-90. DOI: 10.1163/156855803762295440  0.348
2002 Konstan MW, Davis PB. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis. Advanced Drug Delivery Reviews. 54: 1409-23. PMID 12458152 DOI: 10.1016/S0169-409X(02)00146-1  0.379
2002 Schluchter MD, Konstan MW, Davis PB. Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients. Statistics in Medicine. 21: 1271-87. PMID 12111878 DOI: 10.1002/Sim.1104  0.318
2002 Ziady AG, Kelley TJ, Milliken E, Ferkol T, Davis PB. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 413-9. PMID 11945068 DOI: 10.1006/Mthe.2002.0556  0.367
2002 Hilliard JB, Konstan MW, Davis PB. Inflammatory mediators in CF patients. Methods in Molecular Medicine. 70: 409-31. PMID 11917540 DOI: 10.1385/1-59259-187-6:409  0.325
2001 Gupta S, Eastman J, Silski C, Ferkol T, Davis PB. Single chain Fv: a ligand in receptor-mediated gene delivery. Gene Therapy. 8: 586-92. PMID 11320404 DOI: 10.1038/Sj.Gt.3301451  0.344
2001 Kube D, Sontich U, Fletcher D, Davis PB. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. American Journal of Physiology. Lung Cellular and Molecular Physiology. 280: L493-502. PMID 11159033 DOI: 10.1152/Ajplung.2001.280.3.L493  0.366
2001 Kube D, Adams L, Perez A, Davis PB. Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport. American Journal of Physiology. Lung Cellular and Molecular Physiology. 280: L482-92. PMID 11159032 DOI: 10.1152/Ajplung.2001.280.3.L482  0.382
2000 Davis PB, Kercsmar CM. Growth in children with chronic lung disease. The New England Journal of Medicine. 342: 887-8. PMID 10727595 DOI: 10.1056/Nejm200003233421210  0.34
2000 Ferkol T, Eckman E, Swaidani S, Silski C, Davis P. Transport of bifunctional proteins across respiratory epithelial cells via the polymeric immunoglobulin receptor. American Journal of Respiratory and Critical Care Medicine. 161: 944-51. PMID 10712347 DOI: 10.1164/Ajrccm.161.3.9907018  0.36
2000 Xie J, Zhao J, Davis PB, Ma J. Conformation, independent of charge, in the R domain affects cystic fibrosis transmembrane conductance regulator channel openings. Biophysical Journal. 78: 1293-305. PMID 10692317 DOI: 10.1016/S0006-3495(00)76685-9  0.304
2000 van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, Haxhiu MA, Ferkol TW. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. American Journal of Respiratory and Critical Care Medicine. 161: 271-9. PMID 10619831 DOI: 10.1164/Ajrccm.161.1.9903019  0.338
1999 Eckman EA, Mallender WD, Szegletes T, Silski CL, Schreiber JR, Davis PB, Ferkol TW. In vitro transport of active alpha(1)-antitrypsin to the apical surface of epithelia by targeting the polymeric immunoglobulin receptor. American Journal of Respiratory Cell and Molecular Biology. 21: 246-52. PMID 10423408 DOI: 10.1165/Ajrcmb.21.2.3687  0.389
1999 Zerhusen B, Zhao J, Xie J, Davis PB, Ma J. A single conductance pore for chloride ions formed by two cystic fibrosis transmembrane conductance regulator molecules. The Journal of Biological Chemistry. 274: 7627-30. PMID 10075649 DOI: 10.1074/Jbc.274.12.7627  0.305
1998 Ma J, Davis PB. What we know and what we do not know about cystic fibrosis transmembrane conductance regulator. Clinics in Chest Medicine. 19: 459-71, v-vi. PMID 9759549 DOI: 10.1016/S0272-5231(05)70093-9  0.322
1998 Bryan R, Kube D, Perez A, Davis P, Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. American Journal of Respiratory Cell and Molecular Biology. 19: 269-77. PMID 9698599 DOI: 10.1165/Ajrcmb.19.2.2889  0.375
1997 Davis PB. The decline and fall of pulmonary function in cystic fibrosis: new models, new lessons. The Journal of Pediatrics. 131: 789-90. PMID 9427876 DOI: 10.1016/S0022-3476(97)70019-2  0.317
1997 Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. The Journal of Clinical Investigation. 100: 2810-5. PMID 9389746 DOI: 10.1172/Jci119828  0.384
1997 Ziady AG, Perales JC, Ferkol T, Gerken T, Beegen H, Perlmutter DH, Davis PB. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor. The American Journal of Physiology. 273: G545-52. PMID 9277436 DOI: 10.1152/Ajpgi.1997.273.2.G545  0.316
1997 Davis PB, Byard PJ, Konstan MW. Identifying treatments that halt progression of pulmonary disease in cystic fibrosis. Pediatric Research. 41: 161-5. PMID 9029632 DOI: 10.1203/00006450-199702000-00001  0.355
1996 Xie J, Drumm ML, Zhao J, Ma J, Davis PB. Human epithelial cystic fibrosis transmembrane conductance regulator without exon 5 maintains partial chloride channel function in intracellular membranes. Biophysical Journal. 71: 3148-56. PMID 8968585 DOI: 10.1016/S0006-3495(96)79508-5  0.354
1996 Perez A, Risma KA, Eckman EA, Davis PB. Overexpression of R domain eliminates cAMP-stimulated Cl- secretion in 9/HTEo- cells in culture. The American Journal of Physiology. 271: L85-92. PMID 8760136 DOI: 10.1152/Ajplung.1996.271.1.L85  0.325
1995 Chetty A, Davis P, Infeld M. Effect of elastase on the directional migration of lung fibroblasts within a three-dimensional collagen matrix. Experimental Lung Research. 21: 889-99. PMID 8591792 DOI: 10.3109/01902149509031769  0.334
1995 Ferkol T, Perales JC, Eckman E, Kaetzel CS, Hanson RW, Davis PB. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. The Journal of Clinical Investigation. 95: 493-502. PMID 7860731 DOI: 10.1172/Jci117690  0.366
1995 Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. Journal of Clinical Epidemiology. 48: 1041-9. PMID 7775991 DOI: 10.1016/0895-4356(94)00230-N  0.333
1995 Davis PB. Intruder in the dust: why are dust mites such effective allergens? American Journal of Respiratory Cell and Molecular Biology. 12: 367-8. PMID 7695915 DOI: 10.1165/Ajrcmb.12.4.7695915  0.329
1995 Sharma GD, Tosi MF, Stern RC, Davis PB. Progression of pulmonary disease after disappearance of Pseudomonas in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 152: 169-73. PMID 7599818 DOI: 10.1164/Ajrccm.152.1.7599818  0.371
1995 Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. The New England Journal of Medicine. 332: 848-54. PMID 7503838 DOI: 10.1056/Nejm199503303321303  0.363
1995 Xie J, Drumm ML, Ma J, Davis PB. Intracellular loop between transmembrane segments IV and V of cystic fibrosis transmembrane conductance regulator is involved in regulation of chloride channel conductance state. The Journal of Biological Chemistry. 270: 28084-91. PMID 7499295 DOI: 10.1074/Jbc.270.47.28084  0.356
1995 Eckman EA, Cotton CU, Kube DM, Davis PB. Dietary changes improve survival of CFTR S489X homozygous mutant mouse. The American Journal of Physiology. 269: L625-30. PMID 7491981 DOI: 10.1152/Ajplung.1995.269.5.L625  0.315
1994 Davis PB. Evolution of therapy for cystic fibrosis. The New England Journal of Medicine. 331: 672-3. PMID 8052279 DOI: 10.1056/Nejm199409083311011  0.328
1993 Infeld MD, Brennan JA, Davis PB. Human fetal lung fibroblasts promote invasion of extracellular matrix by normal human tracheobronchial epithelial cells in vitro: a model of early airway gland development. American Journal of Respiratory Cell and Molecular Biology. 8: 69-76. PMID 8417759 DOI: 10.1165/Ajrcmb/8.1.69  0.337
1993 Kercsmar CM, Davis PB. Resistance of human tracheal epithelial cells to killing by neutrophils, neutrophil elastase, and Pseudomonas elastase. American Journal of Respiratory Cell and Molecular Biology. 8: 56-62. PMID 8417757 DOI: 10.1165/Ajrcmb/8.1.56  0.351
1993 Ferkol T, Kaetzel CS, Davis PB. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. The Journal of Clinical Investigation. 92: 2394-400. PMID 8227356 DOI: 10.1172/Jci116845  0.356
1992 Infeld MD, Brennan JA, Davis PB. Human tracheobronchial epithelial cells direct migration of lung fibroblasts in three-dimensional collagen gels. The American Journal of Physiology. 262: L535-41. PMID 1590405 DOI: 10.1152/Ajplung.1992.262.5.L535  0.326
1992 Davis PB, Silski CL, Liedtke CM. Amiloride antagonizes beta-adrenergic stimulation of cAMP synthesis and Cl- secretion in human tracheal epithelial cells American Journal of Respiratory Cell and Molecular Biology. 6: 140-145. PMID 1347224 DOI: 10.1165/Ajrcmb/6.2.140  0.341
1991 Fiedler MA, Kaetzel CS, Davis PB. Sustained production of secretory component by human tracheal epithelial cells in primary culture. The American Journal of Physiology. 261: L255-61. PMID 1928359 DOI: 10.1152/Ajplung.1991.261.4.L255  0.316
1991 Davis PB. Cystic fibrosis from bench to bedside New England Journal of Medicine. 325: 575-577. PMID 1906988 DOI: 10.1056/Nejm199108223250809  0.364
1991 Chung Y, Kercsmar CM, Davis PB. Ferret tracheal epithelial cells grown in vitro are resistant to lethal injury by activated neutrophils. American Journal of Respiratory Cell and Molecular Biology. 5: 125-32. PMID 1892642 DOI: 10.1165/Ajrcmb/5.2.125  0.319
1991 Kercsmar CM, Chung Y, Davis PB. Receptor-mediated cAMP production in adult and infant ferret tracheal epithelium. Pediatric Research. 30: 75-82. PMID 1679920 DOI: 10.1203/00006450-199107000-00016  0.314
1990 Orkin Lewin L, Byard PJ, Davis PB. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients Journal of Clinical Epidemiology. 43: 125-131. PMID 2303842 DOI: 10.1016/0895-4356(90)90175-O  0.335
1990 Kercsmar CM, Infeld MD, Silski CL, Davis PB. Adenosine 3:5' cyclic monophosphate synthesis by human tracheal epithelial cells. American Journal of Respiratory Cell and Molecular Biology. 2: 33-9. PMID 2155012 DOI: 10.1165/Ajrcmb/2.1.33  0.326
1990 Konstan MW, Vargo KM, Davis PB. Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis American Review of Respiratory Disease. 141: 186-192. PMID 2153353 DOI: 10.1164/Ajrccm/141.1.186  0.38
1990 Davis PB, Silski CL, Kercsmar CM, Infeld M. Beta-adrenergic receptors on human tracheal epithelial cells in primary culture. The American Journal of Physiology. 258: C71-6. PMID 1689114 DOI: 10.1152/Ajpcell.1990.258.1.C71  0.316
1988 Davis PB, Vargo K. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. Thorax. 42: 120-5. PMID 3433235 DOI: 10.1136/Thx.42.2.120  0.334
1988 Byard PJ, Davis PB. Pulmonary function in obligate heterozygotes for cystic fibrosis. The American Review of Respiratory Disease. 138: 312-316. PMID 3195830 DOI: 10.1164/Ajrccm/138.2.312  0.31
1987 Davis PB. Lymphocyte and granulocyte phosphatidylethanolamine N-methyltransferase: properties and activity in cystic fibrosis. Pediatric Research. 20: 1290-6. PMID 3025802 DOI: 10.1203/00006450-198612000-00021  0.324
1984 Davis PB, Dieckman L, Boat TF, Stern RC, Doershuk CF. The alpha 2-adrenergic system of the platelet in cystic fibrosis. The American Journal of the Medical Sciences. 288: 104-8. PMID 6091455 DOI: 10.1097/00000441-198410000-00002  0.339
1983 Davis PB, Dieckman L, Boat TF, Stern RC, Doershuk CF. Beta adrenergic receptors in lymphocytes and granulocytes from patients with cystic fibrosis. The Journal of Clinical Investigation. 71: 1787-95. PMID 6306054 DOI: 10.1172/Jci110934  0.352
1983 Davis PB, Kaliner M. Autonomic nervous system abnormalities in cystic fibrosis. Journal of Chronic Diseases. 36: 269-78. PMID 6298269 DOI: 10.1016/0021-9681(83)90062-0  0.344
1978 Davis PB, Braunstein M, Jay C. Decreased adenosine 3′:5′-monophosphate response to isoproterenol in cystic fibrosis leukocytes Pediatric Research. 12: 703-707. PMID 209391 DOI: 10.1203/00006450-197806000-00005  0.341
Show low-probability matches.